Sustaining Sponsors

Donors making a three-year commitment of $25,000-$49,999 per year. Their generous support is crucial to Keystone Symposia's ability to plan future scientific conferences focused on emerging topics and excellence in science.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2689

Click here for more information on Industry Support and Recognition Opportunities.
Astellas Pharma Inc. Autolus Therapeutics Bioverativ Therapeutics
Boehringer Ingelheim Pharmaceuticals, Inc. Compass Therapeutics Editas Medicine
EMD Serono Research and Development Institute, Inc. Gilead Sciences, Inc. MedImmune
Moderna MorphoSys AG Novartis Institutes for BioMedical Research
OncoMed Pharmaceuticals, Inc. Sangamo Therapeutics, Inc. Sanofi US
Shire Surface Oncology TESARO, Inc.
Thermo Fisher Scientific Inc.    



Sponsors

Donors contributing $25,000-$49,999. These generous gifts allow us to convene meetings in a wide variety of important areas, many of which are in the early stages of research. Special thanks to these organizations for consistent, annual Sponsor-level support.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2689

Click here for more information on Industry Support and Recognition Opportunities.
AbbVie Inc. Akebia Therapeutics Allen Institute
AstraZeneca Biogen BlueRock Therapeutics
Bristol-Myers Squibb Company Burroughs Wellcome Fund GlaxoSmithKline
ImmunoGen, Inc. Ionis Pharmaceuticals, Inc. Janssen R&D: Pharmaceutical Companies of Johnson & Johnson
Educational grant from Lilly MacroGenics, Inc. Sarepta Therapeutics
10x Genomics Theravance Biopharma Valerion Therapeutics